Turkish laboratory chemical distribution agreement

Solvent supplier, Honeywell, has announced a multi-year distribution agreement with Pro-Lab Laboratuar Teknolojileri, to make the company’s high-purity solvents available in Turkey.

"The annual growth rate of the Turkish pharmaceutical market is estimated to be between 8–9% in the next four years. This places Turkey among the high-potential pharmaceutical markets in the region, and we are glad to have a strong partner there," said Daniel Nott, the regional leader for Honeywell's Health Care and Packaging business in Europe, Middle East and Africa, in a statement.

The solvents are provided for a range of applications in the research, development and approval cycle of pharmaceuticals, including analytical instrumental analysis, such as high-performance liquid chromatography, as well as pilot and full-scale production of pharmaceuticals.

The agreement with Pro-Lab expands the distribution network for the solvent in Europe, the Middle East and Africa. In Germany and Austria, the solvents are distributed by OMNI Life Science; the Irish market is supplied by Reagecon Diagnostics; the Swiss market by Thommen-Furle and the markets in Sweden, Norway and Denmark by Saveen Werner.

For more information, visit www.burdickandjackson.eu or www.pro-lab.com.tr